金鷹股份(600232.SH):全資子公司累計收到徵遷補償款約1.01億元
格隆匯 7 月 6日丨金鷹股份(600232.SH)公佈,公司於2019年9月25日召開第九屆董事會第十二次會議,審議通過了《關於全資子公司擬簽訂徵遷補償協議的議案》,並於2019年10月11日召開2019年第一次臨時股東大會決議通過該議案。嘉興經濟技術開發區塘匯街道下屬國有企業浙江興匯實業有限責任公司徵遷公司的全資子公司浙江金鷹絹紡有限公司的房屋及土地使用權等,此次徵遷的補償價款及補助金額共計為人民幣1.68億元。
近日,浙江金鷹絹紡有限公司收到浙江興匯實業有限責任公司支付的第二筆徵遷補償款,計人民幣約5040.21萬元。截至公告日,公司全資子公司累計收到徵遷補償款人民幣約1.01億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.